A new system can dial expression of synthetic genes up or down

For decades, synthetic biologists have been developing gene circuits that can be transferred into cells for applications such ...

In chromosome of key biotech bacterium, different setups bring different strengths

“Our work is the first to directly test how chromosome structure affects bacterial growth, survival, and ability to cause ...
TipRanks on MSN

Circio Unveils Breakthrough in Gene Therapy with AAV-circVec Technology

Targovax ASA ( ($GB:0RIS) ) has shared an announcement. Circio Holding ASA announced significant advancements in their AAV-circVec technology, ...
GEN

Single-Cell Proteomics Reveal Hidden Layers of Gene Expression

Single cell gene expression studies often rely on single-cell RNA sequencing (scRNA-seq) alone. While scRNA-seq reveals which genes are turned on, it does not capture protein expression or changes to ...
Nasdaq

Krystal Biotech Announces Promising Clinical Data for KB408 Gene Therapy in Alpha-1 Antitrypsin Deficiency Patients and Progress on KB407 for Cystic Fibrosis

Krystal Biotech reports positive clinical data for KB408 and KB407, demonstrating safety and efficacy in AATD and cystic fibrosis patients. Krystal Biotech, Inc. has announced promising clinical ...

Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress

Cellectis’ headquarters are in Paris, France, with locations in New York and Raleigh, NC. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find ...

Absence of key protein scrambles sperm DNA, revealing potential cause of male infertility

Researchers from the Universitat Autònoma de Barcelona (UAB) have published an analysis that reveals new functions of the ...

Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis

Receiving a platform technology designation from the FDA is a tremendous milestone for our development team and Krystal, both as recognition of the reproducibility and scalability of our HSV-1 gene ...

ARTHEx Biotech to Participate in Upcoming Investor and Industry Events

ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing targeted RNA medicines for rare genetic neuromuscular disorders, announced today its participation in the following in ...